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Objectives: Despite the known advantages of the extracardiac conduit Fontan proce-
dure, the long-term outcomes related to the longevity of the conduit and anticoagula-
tion therapy have not been determined. The purpose of this study was to evaluate the
outcome of hospital survivors with an extracardiac Fontan circulation.
Methods and Results:Between 1996 and 2006, 200 patients had the extracardiac con-
duit Fontan operation. The median age at operation was 3.4 years. Most patients
(89.5%) underwent a bidirectional cavopulmonary shunt. Fenestration was required
in 85 patients. Overall, the 10-year survival was 92.4%6 2.1%. Multivariate analysis
identified severe infection during the early postoperative period and a high pulmonary
arterial pressure during the preoperative period as independent risk factors for patient
mortality. The Kaplan–Meier estimate for freedom from reoperation was 82.4% 6
4.1% at 10 years. Arrhythmia occurred in 32 patients after the Fontan operation; free-
dom from arrhythmia was 85.1%6 4.4% at 10 years. The risk factors for arrhythmia
were the heterotaxy syndrome, follow-up duration, and age at Fontan operation. Free-
dom from thromboembolism at 10 years was 92.9% 6 1.9%. Among all of the
patients, 95.2% were classified in New York Heart Association class I.
Conclusions: The results of this study showed that during 10 years of follow-up, the
overall survival and the functional status of the survivors after an extracardiac Fontan
procedure were satisfactory. We might infer that fenestration provided benefit inas-
much as the high-risk Fontan patients fenestrated had similar outcomes to those
not fenestrated, who were presumably low risk. The incidence of late death, reopera-
tion, obstruction of the cavopulmonary pathway, arrhythmias, and thromboembolism
was low.
M
ost patients treated with single ventricle lesions ultimately undergo the
Fontan procedure. The extracardiac conduit Fontan has several advantages
including excellent hemodynamics and low rates of arrhythmia, as well as
being a simple surgical technique.1,2 However, this procedure has potential disadvan-
tages related to using an extracardiac tube, including the lack of growth potential,
conduit stenosis resulting from intimal peel formation, an increased risk of
thromboembolism, and the need for reoperation. Although many other modifications
have been described in the medical literature, few large series have addressed the
long-term outcome, in the current era, after undergoing an extracardiac Fontan mod-
ification. The use of fenestration has reduced the procedure-related morbidity and
mortality in high-risk patients but has the disadvantages of desaturation and paradox-
ical embolism. The purpose of this study was to evaluate the midterm outcome of hos-
pital survivors with extracardiac Fontan circulation and to determine the role of
fenestration in high-risk patients.
Methods
Patient Characteristics
Clinical data obtained from the medical records of 200 patients who received an extracardiac
Fontan operation at the Sejong General Hospital between August 1996 and August 2006 was
reviewed. The records of these patients were reviewed for the operative and perioperative
Lim, Kim SJ, Lee, Kim WH (left to right)
From the Departments of Pediatric Cardiolo-
gya and Cardiothoracic Surgery,b Sejong
General Hospital, Sejong Heart Institute,
Bucheon, Korea, and the Department of
Thoracic and Cardiovascular Surgery, Seoul
National University College of Medicine,
Seoul National University Children’s Hospi-
tal,c Seoul, Korea.
Received for publication Sept 26, 2007;
revisions received Dec 18, 2007; accepted
for publication Dec 27, 2007.
Address for reprints: Woong-Han Kim, MD,
Department of Thoracic & Cardiovascular
Surgery, Clinical Research Institute, Seoul
National University, College of Medicine,
Seoul National University Children’s Hospi-
tal, 28 Yongon-Dong, Jongno-Gu, Seoul,
110-744, Korea (E-mail: woonghan@snu.
ac.kr).
J Thorac Cardiovasc Surg 2008;136:108-16
0022-5223/$34.00
Copyright  2008 by The American Asso-
ciation for Thoracic Surgery
doi:10.1016/j.jtcvs.2007.12.032108 The Journal of Thoracic and Cardiovascular Surgery c July 2008
Kim et al Surgery for Congenital Heart Disease
CH
DAbbreviations and Acronyms
BCPS 5 bidirectional cavopulmonary shunt
PAP 5 pulmonary arterial pressure
PLE 5 protein-losing enteropathy
PVR 5 pulmonary vascular resistance
SaO2 5 arterial oxygen saturation
TPG 5 transpulmonary gradient
features, follow-up echocardiographic, Holter electrocardography,
catheterization, and clinical data. These results were compared be-
tween a group with fenestration and a group without fenestration
procedures. Table I shows the primary diagnoses for the 200 pa-
tients. Sixty-four (32%) patients had a diagnosis of heterotaxy.
The Sejong General Hospital Institutional Review Board reviewed
and approved this study and individual consent was waived.
Surgical Technique
Among the 200 patients, 188 patients had received at least one op-
eration before the bidirectional cavopulmonary shunt (BCPS) or the
Fontan operation. The initial palliations were Blalock–Taussig
shunt in 56 (28.0%), pulmonary banding in 36 (18.0%), coarctation
of the aorta repair in 5, Norwood stage I in 4, atrial septectomy in 3,
Damus–Kaye–Stansel procedure in 2, pulmonary artery angioplasty
in 2, and interrupted aortic arch repair in 1.
All patients (89.5%), except 21 who had a 1-stage Fontan oper-
ation, had a BCPS. Fenestration was required in 85 (42.5%) patients.
The pre-Fontan procedures were as follows: BCPS in 179 (89.5%),
atrial septectomy in 51, pulmonary artery angioplasty in 30, atrio-
ventricular valve repair in 9, Damus–Kaye–Stansel procedure in
4, left ventricular outflow tract obstruction relief in 4, atriopulmo-
nary Fontan in 3, total anomalous pulmonary venous return repair
in 2, permanent pacemaker implantation in 2, aortic valve replace-
ment in 1, atrioventricular valve replacement in 1, coarctation of
aorta repair in 1, and right ventricle exclusion in 1.
At Fontan, patients were operated on through a median sternot-
omy with mild hypothermia and cardiopulmonary bypass. If there
was no planned concomitant intracardiac procedure, the procedure
was basically performed with the heart beating. If we had to make
an atrial septectomy, we transected the inferior vena cava and car-
ried out atrial septectomy under temporary ventricular fibrillation.
An expanded polytetrafluoroethylene tube conduit (Gore-Tex vas-
cular graft; W. L. Gore & Associates, Inc, Flagstaff, Ariz) was
used throughout except for 20 patients; a Hemashield graft (Boston
Scientific, Natick, Mass) was used in 18 patients, and a homograft
in 2. The mean diameter of the conduits used was 18.936 2.24 mm
(range 14.0–24.0 mm) for the entire cohort. The fenestrations were
made with a polytetrafluoroethylene tube graft (median 4 mm,
range 3.5–8 mm). The decision to use fenestrations was made in
the operating room after weaning the patient from cardiopulmonary
bypass. The criteria for using fenestrations were (1) a pulmonary
arterial pressure (PAP) greater than 18 mm Hg or a transpulmonary
gradient (TPG) greater than 10 mm Hg, or both, and (2) risk factors
for a Fontan operation.
The combined procedures included the following: an atrial sep-
tectomy in 43, pulmonary artery angioplasty in 22, atrioventricularThe Journal of Thovalve repair in 20, left ventricular outflow tract obstruction relief in
4, coronary sinus unroofing in 4, permanent pacemaker implantation
in 4, right-sided maze in 3, isthmus cryoablation in 2, Damus–Kaye–
Stansel procedure in 2, aortic valvuloplasty in 2, total anomalous
pulmonary venous return repair in 1, cor triatriatum membrane re-
section in 1, ascending aorta reduction plasty in 1, and tricuspid
valve exclusion in 1.
Statistical Analysis
Statistical analyses were performed with SPSS version 11.0 soft-
ware (SPSS, Inc, Chicago, Ill). All results were expressed as
a mean 6 standard deviation. The differences between the two
groups were assessed by the unpaired Student t test, the c2 test, or
the Fisher exact test. Actuarial data were analyzed by the Kaplan–
Meier formula. Differences between the groups were evaluated by
a log–rank test. The follow-up status of patients was determined
by retrospective review of hospital records or by telephone inter-
views.
Results
Among the 200 patients who underwent the extracardiac
Fontan operation, 109 (54.5%) were male and 91 (45.5%)
were female. The median age at the time of the Fontan op-
eration was 3.4 years (range 16 months to 35.7 years). The
interval between BCPS and Fontan completion was a me-
dian of 26.2 months (range 8.5–154.5 months). A fenestra-
tion was placed in 85 (42.5%) patients. The annual rate of
fenestration placement progressively decreased from 67%
in 1997 to 17% in 2006. Preoperative catheterization data
are detailed in Table 2. The preoperative PAP was signifi-
cantly higher in the fenestration group than in the patients
without fenestration (13.3 6 3.2 vs 11.7 6 3.1 mm Hg;
P 5 .001), as were the preoperative TPG (5.34 6 2.00 vs
4.50 6 1.70 mm Hg; P 5 .003) and the preoperative pul-
monary vascular resistance (PVR) (1.76 6 0.70 vs 1.47
6 0.64 U/m2; P 5 .004).
TABLE 1. Primary diagnosis
Primary diagnosis No (%)
Isomerism 64 (32.0%)
Tricuspid atresia 28 (14.0%)
Congenitally corrected TGA 18 (9.0%)
CAVSD 13 (6.5%)
Mitral atresia 11 (5.5%)
Criss-cross 10 (5.0%)
DIRV 9 (4.5%)
Pulmonary atresia with IVS 7 (3.5%)
DILV 6 (3.0%)
HLHS 4 (2.0%)
Ebstein anomaly 3 (1.5%)
Other complex 27 (13.5%)
Total 200 (100%)
TGA, Transposition of the great arteries; CAVSD, complete atrioventricular
septal defect; DIRV, double-inlet right ventricle; IVS, intact ventricular sep-
tum; DILV, double-inlet left ventricle; HLHS, hypoplastic left heart syndrome.racic and Cardiovascular Surgery c Volume 136, Number 1 109
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DTABLE 2. Catheterization data before and after the Fontan operation
Variable Total (n 5 200) Fenestration (n 5 85) No fenestration (n 5 115) P value
Preoperative
PAP (mm Hg) 12.4 6 3.3 13.3 6 3.2 11.7 6 3.1 .001
VEDP (mm Hg) 9.97 6 3.33 10.15 6 3.78 9.84 6 2.96 .524
TPG (mm Hg) 4.85 6 1.87 5.34 6 2.00 4.50 6 1.70 .003
PVR (U/m2) 1.60 6 0.68 1.76 6 0.70 1.47 6 0.64 .004
Last follow-up
PAP (mm Hg) 14.0 6 3.6 14.4 6 3.6 13.7 6 3.7 .351
VEDP (mm Hg) 10.9 6 3.8 10.8 6 3.4 11.0 6 4.1 .787
TPG (mm Hg) 4.81 6 1.99 4.86 6 2.07 4.76 6 1.92 .829
PVR (U/m2) 1.61 6 0.84 1.78 6 0.93 1.46 6 0.72 .100
SaO2 (%) 91.8 6 4.6 90.8 6 4.4 92.6 6 4.6 .044
Qs (L $ min21 $ m22) 3.90 6 1.22 3.84 6 1.37 3.96 6 1.07 .665
PAP, Pulmonary artery pressure; VEDP, ventricular end-diastolic pressure; TPG, transpulmonary gradient; PVR, pulmonary vascular resistance; SaO2, arterial
oxygen saturation; Qs, cardiac index.The last follow-up catheterization data are shown in Table
2. Follow-up catheterization was performed in 53.5% pa-
tients at a mean follow up of 35.76 23.3 months. The arterial
oxygen saturation (SaO2) was significantly lower in the fenes-
tration group than in the group without fenestration (90.8%6
4.4% vs 92.6%6 4.6%; P5 .044). The other catheterization
data, such as PAP, ventricular end-diastolic pressure, TPG,
PVR, SaO2, and cardiac index, demonstrated no statistically
significant differences.
Mortality and Risk Factors for Death
The hospital mortality was 3.0% (n5 6) and the late mortal-
ity was 3.6% (n 5 7) with a mean follow-up of 52.4 6 32.2
months (range 18 days to 120 months) for the entire cohort.
The hospital mortality rate was 4.7% (n5 4) in patients with
fenestration and 1.7% (n 5 2) in those without fenestration
(P 5 .224). There were 4 (4.9%) late deaths in patients
with fenestration and 3 (2.7%) late deaths in patients without
fenestration. The 10-year survival was 92.4%6 2.1% for the
entire cohort. The 10-year survival was 90.3% 6 3.3% in
patients with fenestration and 93.7%6 3.0% in patients with-
out fenestration. There was no significant difference in sur-
vival between the two groups (P 5 .21, log–rank test)
(Figure 1).
Univariate analysis indicated that a postoperative severe
infection (mediastinitis) (P5 .001), protein-losing enteropa-
thy (PLE) after the Fontan operation (P 5 .008), and a high
PAP during the preoperative period (P5 .003) were statisti-
cally significant risk factors. Multivariate analysis identified
postoperative severe infection (hazard ratio5 12.439;P5 .001)
Figure 1. Survival. A, Kaplan–Meier curve for the entire cohort. B, Kaplan–Meier survival curve for patients with
a fenestration (dashed line) and without a fenestration (solid line).
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Dand high PAP during the preoperative period (hazard ratio
5 3.445; P 5 .038) as risk factors for mortality. The het-
erotaxy syndrome, anatomic factors, other hemodynamic
data, fenestration, arrhythmia, and thrombosis were not
significant risk factors for death in this study (Table 3).
Early Postoperative Data
Postoperative central venous pressure was significantly
higher in patients with fenestration than in those without
fenestration (15.6 6 2.5 vs 14.6 6 2.5; P 5 .008) and post-
operative SaO2 was significantly lower in patients with fen-
estration than in those without fenestration (90.6% 6 5.4%
vs 94.4%6 6.1%; P5 .001). The postoperative low cardiac
output syndrome occurred more frequently in the fenestra-
tion group than in those patients without fenestration
(7.1% vs 1.7%; P 5 .058). There was no significant differ-
ence of other postoperative hemodynamic data such as blood
pressure, urine output, ventilator care, a chest tube drain,
chylothorax, neurologic sequalae, infection, and respiratory
failure among patients with and without fenestration.
Reoperations
Reoperation was performed in 24 (12.0%) patients and the
Kaplan–Meier estimate for freedom from reoperation was
82.4% 6 4.1% at 10 years (Figure 2). Reoperation includes
revision of a conduit (n5 7), revision or addition of fenestra-
tion (n5 6), repair of atrioventricular valve (n5 5), insertion
of a permanent pacemaker (n 5 5), angioplasty of a pulmo-
nary artery (n 5 4), takedown of the Fontan conduit and
hepatic vein–azygos vein anastomosis (n 5 3), atrial septec-
tomy, unroofing of the coronary sinus, and widening of the
left ventricular outflow tract. The causes of revision of a con-
duit (n 5 7) were as follows: One patient had coagulopathy
owing to protein C deficiency and needed conduit revisionwith removal of a large thrombus. In early series, a Hema-
shield conduit was used in several patients, and one of
them showed early concentric stenosis of the conduit neces-
sitating revision. One patient with heterotaxy syndrome had
wide separate drainage of left hepatic veins and showed per-
sistent cyanosis after the Fontan procedure. Revision of the
conduit was needed to include the residual hepatic vein.
Three other patients had low cardiac output after the Fontan
operation. Two of them had mediastinitis and 1 had PLE.
Thrombo-occlusion of the Fontan pathway was detected dur-
ing long hospital stays even with strict anticoagulation. All 3
TABLE 3. Risk factors for mortality
Multivariate
Variables
Univariate
P value P value Hazard ratio 95% CI
Heterotaxy .476 .778
AV valve .678 .282
Ventricle type .988 .679
Abnormal PVD .369 .327
Preop. PAP .
15 mm Hg
.003 .038 3.445 1.073–1.057
Preop. VEDP .
10 mm Hg
.143 .850
Fenestration .132 .113
Postop. CVP .
15 mm Hg
.351 .914
Infection .001 .001 12.439 3.806–40.657
PLE .006 .301
Arrhythmia .171 .689
Thrombosis .717 .845
AV, Atrioventricular; PVD, peripheral vascular disease; PAP, pulmonary ar-
tery pressure; VEDP, ventricular end-diastolic pressure; CVP, central venous
pressure; PLE, protein-losing enteropathy.Figure 2. Kaplan–Meier curve of freedom from
reoperation.
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Dpatients had surgical removal of thrombus with conduit revi-
sion. The causes of conduit revision were assocated with
post-Fontan hemodynamic state or coagulopathy.
Revision or addition of fenestration was performed more
frequently in patients with fenestration (5.9%) than in those
without fenestration (0.9%), and this difference was statisti-
cally significant (P5 .040). There were no significant differ-
ences with regard to reoperation between the two groups. The
need for reoperation over the 10-year period was not signif-
icantly different between the groups with and without fenes-
tration (88.4% 6 3.6% vs78.0% 6 6.1%; P 5 .21).
Arrhythmia
Arrhythmia occurred in 32 (16.0%) patients after the Fontan
operation. Bradyarrhythmia occurred in 26 patients; sinus
node dysfunction developed in 22, sinus bradycardia in 1,
and atrioventricular block in 3. A permanent pacemaker im-
plantation was required in 12 patients. Tachyarrhythmia
occurred in 10 patients; paroxysmal supraventricular tachy-
cardia in 8, atrial flutter in 2, and junctional ectopic tachycar-
dia in 1. Fifteen (7.5%) patients had early postoperative
arrhythmias and 15 (7.7%) had late postoperative arrhyth-
mias. The Kaplan–Meier estimate of freedom from overall ar-
rhythmia at 10 years was 79.8% 6 3.7% and freedom from
late arrhythmia at 10 years was 85.1% 6 4.4% (Figure 3,
A). Risk factors for arrhythmia included heterotaxy syndrome
(hazard ratio5 3.914; P5 .001), follow-up duration (hazard
ratio 5 0.986; P 5 .027), and age at the Fontan operation
(hazard ratio 5 1.151; P 5 .001). The risk factor for late
bradyarrhythmia was left isomerism (hazard ratio 5 3.479;
P 5 .038).
The Kaplan–Meier estimates of freedom from tachyar-
rhythmia were 98.4%6 0.9% at 10 years. The Kaplan–Meier
estimates of freedom from bradyarrhythmia were 88.0% 6
3.7% at 10 years. There was a statistically significant differ-
ence in the type of late arrhythmia (P 5 .007) (Figure 3, B).
The Kaplan–Meier estimate of freedom from late arrhythmia
at 10 years was 74.9%6 8.9% and of freedom from late bra-
dyarrhythmia was 66.9%6 16.5% at 10 years in heterotaxy.
The patients with heterotaxy had a higher incidence of late
arrhythmia and late bradyarrhythmia than nonheterotaxy
patients (P 5 .015 and P 5 .007, respectively) (Figure 3, C
and 3, D).
Thromboembolism
Thromboembolism occurred in 13 (6.5%) patients. The
Kaplan–Meier estimate of freedom from thromboembolism
was 92.9% 6 1.9% at 10 years (Figure 4). Most patients
(11/13, 84.6%) who had a thromboembolism sustained the
complication within 1 year after the Fontan procedure. Six
of these patients underwent surgical management (Table 4).
Among the 13 patients who had a thromboembolism, 1
(7.69%) patient died; among the 187 patients without a throm-
boembolism, 12 (6.42%) died. There was no statistically sig-112 The Journal of Thoracic and Cardiovascular Surgery c Junificant difference in mortality according to the occurrence of
thromboembolism (P 5 .86).
Other Complications and Follow-up
PLE was observed in 5 patients. PLE occurred more fre-
quently in the fenestration group than in those without fenes-
tration (4.7% vs 0.9%; P 5 .086), although this difference
did not reach statistical significance. Two patients died and
3 patients improved after medical treatment with heparin
or/and supportive management. Four patients who had left
isomerism had a persistent pulmonary arteriovenous malfor-
mation even after Fontan completion and required reopera-
tion to provide an even distribution of hepatic blood flow
to both lungs. There were 25.4% (50/197) who showed sys-
temic ventricular dysfunction and 11.1% (22/198) who had
atrioventricular regurgitation of more than a moderate degree
with a mean follow-up duration of 37.76 30.2 months (0.2–
108.3 months).
Follow-up information on the functional status and medi-
cation were available for 187 patients (93.5%), 95.2% (n 5
178) met the criteria for the New York Heart Association
functional class I, and 4.8% (n5 9) met the criteria for func-
tional class II. Anticoagulation was provided with aspirin in
170 patients (90.9%) and with warfarin sodium (Coumadin)
in 17 (9.1%). Cardiovascular medication was provided in 87
(46.5%) patients and antiarrhythmic medication in 2 (1.1%).
There was no statistically significant difference in functional
class and medication between the patients with fenestration
and those without fenestration.
Extracardiac Conduit and Fenestration
Recently, we3 reported the change in status of polytetra-
fluoroethylene grafts used in the extracardiac conduit Fontan
procedure. In 48 patients who underwent follow-up catheter-
ization, the internal diameter of the conduit and inferior vena
cava were measured angiographically. The mean conduit–
inferior vena cava cross-sectional area was 1.25 6 0.33.
The mean percent decrease of the conduit cross-sectional
area was 14.3% 6 8.5% with a mean follow-up duration
of 36.1 6 19.7 months. Follow-up duration and the percent
decrease of the conduit cross-sectional area did not show
a significant correlation (r 5 0.22; P 5 .14). Among the
34 patients who underwent a fenestrated Fontan operation
and follow-up catheterization later, 74% (n 5 25) showed
a spontaneous closure of the fenestration after a median of
25 months (range 4–67 months). All patients who had
a 3.5-mm fenestration had it close spontaneously and none
with a 6-mm fenestration had spontaneous closure. Most
fenestrations closed spontaneously within 22 months after
the Fontan operation.
Discussion
Since the introductionof the total cavopulmonary anastomosis
by Fontan and Baudet4 more than 30 years ago, modificationsly 2008
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DFigure 3. Kaplan–Meier curve of freedom from arrhythmia. A, Kaplan–Meier curve of freedom from overall arrhyth-
mias (b, dashed line) and freedom from late arrhythmias (a, solid line).B, According to the type of late arrhythmia, the
Kaplan–Meier curve for tachyarrhythmias (a, solid line), for bradyarrhythmias (c, thin dashed line), and for a perma-
nent pacemaker (b, thick dashed line) are shown. C, Kaplan–Meier curve for late arrhythmias in patients with het-
erotaxy syndrome (dashed line) and without heterotaxy syndrome (solid line). D, Kaplan–Meier curve for late
bradyarrhythmias in patients with heterotaxy syndrome (dashed line) and without heterotaxy syndrome (solid line).of the Fontan procedure and stagingwithBCPShave extended
the indications for this operation, which is now applied to
a wide range of congenital heart defects unsuitable for biven-
tricular repair.5,6 Furthermore, the creation of fenestration in
the Fontan pathway reduces early mortality and morbidity
even in patents for whom the risk of Fontan completion isThe Journal of Thohigh.7 Despite the improvements in surgical techniques that
have reduced the perioperativemortality,8-10 late deterioration
in functional status has been observed with a longer duration
of follow-up.11-13
The significant evolution of the Fontan procedure has
been associated with improvements in early mortality fromracic and Cardiovascular Surgery c Volume 136, Number 1 113
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DFigure 4. Kaplan–Meier curve of freedom from
thromboembolism.20% to 40% in the late 1970s to below 6.6% currently.14 In
earlier studies, midterm and long-tem survival revealed the
potentially finite life span of a Fontan circulation, with the
overall 1-, 5-, and 10-year survivals found to be 77%, 70%,
and 60%, respectively, in the Mayo Clinic study.15 Follow-
up also often suggested a poor functional capacity. At 5
years, only 26% of patients were free from significant cardiac
symptoms.16 Similarly, the early mortality rate was low
(3.3%) in this study, despite the presence of heterotaxy,
known to be a high risk factor for the Fontan operation; our
study population included many patients with the heterotaxy
syndrome (32%, n5 64). However, consistent with the find-
ings of others, we have demonstrated an improved late out-
come with a 10-year survival of 92.4% 6 2.1%.17 The
majority of these patients at a median follow-up of 6 years
TABLE 4. Thromboembolism
Type of thromboembolism No.
Surgical management 6
Conduit thrombosis 5
Conduit change 3
Left HV to PA 1
Conduit thrombectomy 1
PV thrombosis 1
Medical management 7
Cerebral infarction 3
Conduit thrombosis 2
IVC thrombosis 1
LPA thrombosis 1
HV, Hepatic vein; PA, pulmonary artery; PV, pulmonary vein; IVC, inferior
vena cava; LPA, left pulmonary artery.114 The Journal of Thoracic and Cardiovascular Surgery c Juwere in New York Heart Association functional class I or
II (95.2% vs 4.8%).
Medical therapy such as angiotensin-converting enzyme
inhibitors and the long-term benefits of anticoagulation
may have contributed to the improved long-term outcome
of these patients. Our policy is to maintain all patients on
low-dose aspirin, except for high-risk patients. In addition,
angiotensin-converting enzyme inhibitors are used in patients
with evidence of impaired ventricular function or atrioven-
tricular valve regurgitation.
Late morbidity commonly includes pathway obstruc-
tion,18 atrial arrhythmia,19-21 cyanosis because of systemic
venous collateralization,22 thrombus formation,23 PLE,24
and pulmonary arteriovenous malformation.25,26 In compar-
ison with other modifications of the Fontan operation, the re-
operation rate resulting from pathway obstruction or cyanosis
from right-to-left shunting as well as tachyarrhythmias was
very low. These low rates are thought to be among the advan-
tages associated with the extracardiac modification. In this
study, despite the use of the extracardiac conduit and antico-
agulation with aspirin, the incidence of thromboembolism
was not more than in previous reports. This may suggest
that the thromboembolism risk is more closely associated
with suboptimal hemodynamics or an underlying coagulop-
athy than the conduit itself. The conduit cross-sectional
area decreased by 14%, and this did not differ according to
the conduit size used. The extent of decrease of the conduit
cross-sectional area remained stable regardless of the fol-
low-up duration. However, longer follow-up is needed to de-
termine the development of stenosis as the patients grow.
Considering the high incidence of heterotaxy syndrome
(32%), the incidence of early and late postoperatively 2008
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Darrhythmiawas relatively low and, in particular, the incidence
of tachyarrhythmia was rare in our study population. The
incidence of tachyarrhythmia during follow-up was rare.
The only risk factor for bradyarrhythmia during follow-up
was left isomerism. This suggests that the extracardiac Fontan
modification reduces the incidence of postoperative arrhyth-
mia, as reported by a previous study.27
There is much debate regarding the pros and cons of the
Fontan circuit fenestration. Some studies have found that
the fenestrations significantly reduce the duration of postop-
erative effusions, length of time in the hospital, and in some
centers early mortality.10,28 The disadvantages of the fenes-
trations have been reported to be the ongoing risk for a para-
doxical embolus, persistent cyanosis, and an increased
incidence of late catheter intervention for device closure of
the fenestration. Therefore, the overall benefit of routine fen-
estration in Fontan patients remains uncertain.29 In this study,
the high-risk patients required fenestration during the Fontan
operation with high PAP, TPG, and PVR preoperatively. It is
interesting that they showed good hemodynamic parameters
similar to those of patients who were not considered at high
risk postoperatively. In addition, the early outcome of the
high-risk group was comparable with that of the groups con-
sidered not to be at a high risk (early mortality 4.7% vs 1.7%;
P 5 .224). Fortunately, catheter reintervention after the
Fontan procedure was infrequent because the spontaneous
closure rate of the fenestration was high (74%) without the
subsequent need for fenestration, and residual right-to-left
shunt leak was infrequent. However, because of the benefi-
cial long-term effects of fenestration, the need for permanent
fenestration should be considered at least for some patients
despite the risk of thromboembolism.
Conclusions
After 10 years of follow-up, the overall survival and the func-
tional status of survivors after the extracardiac Fontan proce-
dure were satisfactory. We might infer that fenestration
provided benefit because the Fontan patients undergoing fen-
estration, who were at high risk, had similar outcomes to
those not fenestrated, who were presumably at low risk. To
clarify this, a large prospective randomized study is needed.
The incidence of late deaths, reoperations, obstructions of the
cavopulmonary pathway, arrhythmias, and thromboembo-
lism was low.
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